The company started its exports with six drugs and launched formal promotion of the drugs in Sri Lanka from January 1 this year, according to a company statement released yesterday.

The drugs of four generics include Azithrocin® (Azithromycin), Decomit® (Beclomethasone dipropionate), Cox® B (celecoxib) and Deflux® (Domperidone).

"In Sri Lanka, we want to introduce technology-driven specialised products such as inhaler, nasal spray, suppository and injectables. In this connection, Beximco Pharma has already applied for the registration of 28 more new products in Sri Lanka," said Beximco Pharma Chief Executive Officer Nazmul Hassan.

Hassan also said Beximco Pharma has a strong track record of transferring 'technical know-how' to some of the leading companies in Asia and if there is any such opportunity in Sri Lanka, the company will transfer 'technical know-how' to Sri Lanka as well.

Emerchemie NB (Ceylon) Limited will be responsible for registration, import, sales and distribution of Beximco Pharma products in Sri Lanka.

Sri Lanka is the fourth Saarc country where Beximco Pharma has launched its operations. Other countries are Pakistan, Nepal and Bhutan.